Abstract
Genomic copy-number variations (CNVs) constitute an important cause of epilepsies and other human neurological disorders. Recent advancement of technologies integrating genome-wide CNV mapping and sequencing is rapidly expanding the molecular field of pediatric neurodevelopmental disorders. In a previous study, a novel epilepsy locus was identified on 6q16.3q22.31 by linkage analysis in a large pedigree. Subsequent array comparative genomic hybridization (array CGH) analysis of four unrelated cases narrowed this region to ∼5 Mb on 6q22.1q22.31. We sought to further narrow the critical region on chromosome 6q22. Array CGH analysis was used in genome-wide screen for CNVs of a large cohort of patients with neurological abnormalities. Long-range PCR and DNA sequencing were applied to precisely map chromosomal deletion breakpoints. Finally, real-time qPCR was used to estimate relative expression in the brain of the candidate genes. We identified six unrelated patients with overlapping microdeletions within 6q22.1q22.31 region, three of whom manifested seizures. Deletions were found to be de novo in 5/6 cases, including all subjects presenting with seizures. We sequenced the deletion breakpoints in four patients and narrowed the critical region to a ∼250-kb segment at 6q22.1 that includes NUS1, several expressed sequence tags (ESTs) that are highly expressed in the brain, and putative regulatory sequences of SLC35F1. Our findings indicate that dosage alteration in particular, of NUS1, EST AI858607, or SLC35F1 are important contributors to the neurodevelopmental phenotype associated with 6q22 deletion, including epilepsy and tremors.
Similar content being viewed by others
Login or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Ramocki MB, Bartnik M, Szafranski P et al: Recurrent distal 7q11.23 deletion including HIP1 and YWHAG identified in patients with intellectual disabilities, epilepsy, and neurobehavioral problems. Am J Hum Genet 2010; 87: 857–865.
Paciorkowski AR, Thio LL, Rosenfeld JA et al: Copy number variants and infantile spasms: evidence for abnormalities in ventral forebrain development and pathways of synaptic function. Eur J Hum Genet 2011; 19: 1238–1245.
Bassuk AG, Geraghty E, Wu S et al: Deletions of 16p11.2 and 19p13.2 in a family with intellectual disability and generalized epilepsy. Am J Med Genet A 2013; 161A: 1722–1725.
Helbig I, Hartmann C, Mefford HC : The unexpected role of copy number variations in juvenile myoclonic epilepsy. Epilepsy Behav 2013; 28 (Suppl 1): S66–S68.
Mullen SA, Carvill GL, Bellows S et al: Copy number variants are frequent in genetic generalized epilepsy with intellectual disability. Neurology 2013; 81: 1507–1514.
Poduri A, Wang Y, Gordon D et al: Novel susceptibility locus at chromosome 6q16.3-22.31 in a family with GEFS+. Neurology 2009; 73: 1264–1272.
Rosenfeld JA, Amrom D, Andermann E et al: Genotype-phenotype correlation in interstitial 6q deletions: a report of 12 new cases. Neurogenetics 2012; 13: 31–47.
Boone PM, Bacino CA, Shaw CA et al: Detection of clinically relevant exonic copy-number changes by array-CGH. Hum Mutat 2010; 31: 1326–1342.
Szafranski P, Schaaf CP, Person RE et al: Structures and molecular mechanisms for common 15q13.3 microduplications involving CHRNA7: benign or pathological? Hum Mutat 2010; 31: 840–850.
Ballif BC, Theisen A, McDonald-McGinn DM et al: Identification of a previously unrecognized microdeletion syndrome of 16q11.2q12.2. Clin Genet 2008; 74: 469–475.
Duker AL, Ballif BC, Bawle EV et al: Paternally inherited microdeletion at 15q11.2 confirms a significant role for the SNORD116 C/D box snoRNA cluster in Prader-Willi syndrome. Eur J Hum Genet 2010; 18: 1196–1201.
Hastings PJ, Lupski JR, Rosenberg SM, Ira G : Mechanisms of change in gene copy number. Nat Rev Genet 2009; 10: 551–564.
Battaglia A, Guerrini R : Chromosomal disorders associated with epilepsy. Epileptic Disord 2005; 7: 181–192.
Mefford HC, Muhle H, Ostertag P et al: Genome-wide copy number variation in epilepsy: novel susceptibility loci in idiopathic generalized and focal epilepsies. PLoS Genet 2010; 6: e1000962.
Heinzen EL, Radtke RA, Urban TJ et al: Rare deletions at 16p13.11 predispose to a diverse spectrum of sporadic epilepsy syndromes. Am J Hum Genet 2010; 86: 707–718.
Mefford HC, Yendle SC, Hsu C et al: Rare copy number variants are an important cause of epileptic encephalopathies. Ann Neurol 2011; 70: 974–985.
Sisodiya SM, Mefford HC : Genetic contribution to common epilepsies. Curr Opin Neurol 2011; 24: 140–145.
Bartnik M, Szczepanik E, Derwińska K et al: Application of array comparative genomic hybridization in 102 patients with epilepsy and additional neurodevelopmental disorders. Am J Med Genet B Neuropsychiatr Genet 2012; 159B: 760–771.
Miao RQ, Gao Y, Harrison KD et al: Identification of a receptor necessary for Nogo-B stimulated chemotaxis and morphogenesis of endothelial cells. Proc Natl Acad Sci USA 2006; 103: 10997–11002.
Schwab ME : Functions of Nogo proteins and their receptors in the nervous system. Nat Rev Neurosci 2010; 11: 799–811.
Harrison KD, Miao RQ, Fernandez-Hernándo C, Suárez Y, Dávalos A, Sessa WC : Nogo-B receptor stabilizes Niemann-Pick type C2 protein and regulates intracellular cholesterol trafficking. Cell Metab 2009; 10: 208–218.
Nishimura M, Suzuki S, Satoh T, Naito S : Tissue-specific mRNA expression profiles of human solute carrier 35 transporters. Drug Metab Pharmacokinet 2009; 24: 91–99.
Aravin AA, Sachidanandam R, Girard A, Fejes-Toth K, Hannon GJ : Developmentally regulated piRNA clusters implicate MILI in transposon control. Science 2007; 316: 744–747.
Dharmadhikari AV, Kang SH, Szafranski P et al: Small rare recurrent deletions and reciprocal duplications in 2q21.1, including brain-specific ARHGEF4 and GPR148. Hum Mol Genet 2012; 21: 3345–3355.
Dittwald P, Gambin T, Szafranski P et al: NAHR-mediated copy-number variants in a clinical population: mechanistic insights into both genomic disorders and Mendelizing traits. Genome Res 2013; 23: 1395–1409.
Acknowledgements
We thank the families for participating in the study. Dr Seema R Lalani is supported by grants from the Doris Duke Charitable Foundation (DDCF) and Gillson Longenbaugh Foundation.
DISCLAIMER
We confirm that we have read the Journal’s position on issues involved in ethical publication and affirm that this report is consistent with those guidelines.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The Department of Molecular and Human Genetics at Baylor College of Medicine offers extensive genetic laboratory testing, including chromosomal microarray analysis, and derives revenue from this activity. Jill A Rosenfeld is an employee of Signature Genomic Laboratories, a subsidiary of PerkinElmer Inc. The remaining authors declare no conflict of interest.
Additional information
Supplementary Information accompanies this paper on European Journal of Human Genetics website
Supplementary information
Rights and permissions
About this article
Cite this article
Szafranski, P., Von Allmen, G., Graham, B. et al. 6q22.1 microdeletion and susceptibility to pediatric epilepsy. Eur J Hum Genet 23, 173–179 (2015). https://doi.org/10.1038/ejhg.2014.75
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ejhg.2014.75
This article is cited by
-
Morphological and behavioral analysis of Slc35f1-deficient mice revealed no neurodevelopmental phenotype
Brain Structure and Function (2023)
-
The role of de novo mutations in adult-onset neurodegenerative disorders
Acta Neuropathologica (2019)
-
Expression of Slc35f1 in the murine brain
Cell and Tissue Research (2019)
